Tag #Vitamin C

What is the key finding of the University of Iowa study on high-dose vitamin C in treating pancreatic cancer?

A University of Iowa study showed that high-dose intravenous vitamin C (75 grams, three times weekly) given alongside chemotherapy doubled the overall survival rate for late-stage pancreatic cancer patients from eight to sixteen months and increased progression-free survival from four to six months. These findings, published in Redox Biology, resulted from 20 years of research and suggest a potential breakthrough in cancer treatment.